Brainstorm Cell Therapeutics reported $7.37M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US 9.72M 3.86M
Biogen BIIB:US $ 5018M 1071.4M
Brainstorm Cell Therapeutics BCLI:US $ 7.37M 1.06M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Cytokinetics CYTK:US $ 66.84M 0M
Gilead Sciences GILD:US $ 9220M 662M
Halozyme Therapeutics HALO:US $ 199.51M 87.82M
Idera Pharmaceuticals IDRA:US $ 4.74M 0.94M